<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04835116</url>
  </required_header>
  <id_info>
    <org_study_id>AFIU Rawalpindi</org_study_id>
    <nct_id>NCT04835116</nct_id>
  </id_info>
  <brief_title>Comparison of Post-Operative Analgesia After Percutaneous Nephrolithotomy.</brief_title>
  <official_title>Comparison of Post-Operative Analgesia With Peri Tract Local Anesthesia Infiltration and Oral Analgesia Versus Post-Operative Intravenous Analgesia After Percutaneous Nephrolithotomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Armed Forces Institute of Urology, Rawalpindi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Armed Forces Institute of Urology, Rawalpindi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rationale of this study was to compare the efficacy of peri-tract bupivacaine&#xD;
      infiltration with intravenous post-operative analgesia following PCNL in reference to the&#xD;
      context with the previous studies so that we can adopt the better technique to curtail the&#xD;
      post-operative pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rationale of this study was to compare the efficacy of peri-tract bupivacaine&#xD;
      infiltration with intravenous postoperative analgesia following PCNL in reference to the&#xD;
      context with the previous studies so that we can adopt the better technique to curtail the&#xD;
      post-operative pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 11, 2019</start_date>
  <completion_date type="Actual">October 11, 2019</completion_date>
  <primary_completion_date type="Actual">October 11, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Post-Operative Analgesia With Peri Tract Local Anesthesia Infiltration and Oral Analgesia Versus Post-Operative Intravenous Analgesia After Percutaneous Nephrolithotomy.</measure>
    <time_frame>6 months</time_frame>
    <description>Efficacy of peri-tract infiltration of bupivacaine over standard oral analgesia in patients undergoing PCNL.&#xD;
Measurement: Postoperative pain Measurement tool: Visual analog scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Pain</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Local Anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group A patients received peri tract local anaesthesia infiltration with 0.25% Bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous Analgesics</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group B patients received postoperative intravenous analgesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride 0.25% Injection. Paracetamol 650mg. Orphenadrine 50mg.</intervention_name>
    <description>Group A patients were administered per-operative peri tract local anesthesia infiltration with 0.25% bupivacaine augmented by post-operative oral analgesia with a combination of Paracetamol 650 mg and Orphenadrine 50mg 6 hourly.</description>
    <arm_group_label>Intravenous Analgesics</arm_group_label>
    <arm_group_label>Local Anesthesia</arm_group_label>
    <other_name>Local Anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol 1000mg. Tramadol 50mg. Dimenhydrinate 50mg.</intervention_name>
    <description>Group B patients were only given post-operative intra-venous analgesia by Paracetamol 1gm intravenous 8 hourly augmented with a combination of Tramadol 50mg and Dimenhydrinate 50mg as and when required</description>
    <arm_group_label>Intravenous Analgesics</arm_group_label>
    <arm_group_label>Local Anesthesia</arm_group_label>
    <other_name>Intravenous analgesic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients undergoing PCNL&#xD;
&#xD;
          -  age from 12-65 years&#xD;
&#xD;
          -  normal renal functions&#xD;
&#xD;
          -  no history of chronic pain&#xD;
&#xD;
          -  ASA I, II &amp; III&#xD;
&#xD;
          -  Both genders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of local anaesthesia allergy&#xD;
&#xD;
          -  Redo PCNL&#xD;
&#xD;
          -  Multiple punctures during PCNL&#xD;
&#xD;
          -  Excessive intra-operative bleeding&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Mental disorder&#xD;
&#xD;
          -  ASA IV &amp; V&#xD;
&#xD;
          -  Active urinary tract infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Musab Umair, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Armed Forces Institute of Urology.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Armed Forces Institute of Urology.</name>
      <address>
        <city>Rawalpindi</city>
        <state>Punjab</state>
        <zip>47040</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 28, 2021</study_first_submitted>
  <study_first_submitted_qc>April 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 10, 2021</last_update_submitted>
  <last_update_submitted_qc>April 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Armed Forces Institute of Urology, Rawalpindi</investigator_affiliation>
    <investigator_full_name>Musab Umair Khalid</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Local anesthesia, Percutaneous nephrolithotomy.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Orphenadrine</mesh_term>
    <mesh_term>Dimenhydrinate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

